John McKune, Corporate Controller & Principal Accounting Office at KalVista Pharmaceuticals, holds 0.00 shares in KalVista Pharmaceuticals (Ticker: KALV), holds 61.81K shares in Pulmonx (Ticker: LUNG). Most recently, John McKune ― shares of KalVista Pharmaceuticals on ― for an estimated value of ―.